Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jan;34(1):e14637.
doi: 10.1111/dth.14637. Epub 2020 Dec 15.

Topical and systemic retinoids for the treatment of cutaneous viral warts: A systematic review and meta-analysis

Meital Oren-Shabtai  1   2 , Igor Snast  1   2 , Yehonatan Noyman  1   2 , Moshe Lapidoth  1   2 , Shany Sherman  1   2 , Daniel Mimouni  1   2 , Emmilia Hodak  1   2 , Assi Levi  1   2
Affiliations
Meta-Analysis

Topical and systemic retinoids for the treatment of cutaneous viral warts: A systematic review and meta-analysis

Meital Oren-Shabtai et al. Dermatol Ther. 2021 Jan.

Abstract

Cutaneous viral warts (CVW), caused by human papillomavirus, often have a self-limited course. However, some patients experience a recalcitrant disease despite treatment. Retinoids are considered the mainstay of therapy in many dermatologic diseases. Data on their use for viral warts are limited. To systematically review the published evidence on the efficacy and safety of retinoids for the treatment of CVW. A systematic review and meta-analysis of topical or systemic retinoid treatment for CVW was performed in accordance with the PRISMA statement. The primary outcome was clinical response; secondary outcomes were recurrence rate and adverse events. Fourteen publications including 399 patients treated exclusively with retinoids (65% topical, 35% systemic) were evaluated. The complete response rate was 64% (95% CI, 46-78%; I2 =80%) for topical treatment and 61% (95% CI, 44-76%; I2 =69%) for systemic treatment. The most common side effects were irritant contact dermatitis and cheilitis, respectively. Relapse rates were 6% and 17%, respectively. The reviewed studies were considerably heterogenous and most lacked a control group. Both topical and systemic retinoids are effective and safe as monotherapy for CVW. Further studies are required to determine their exact role in this setting.

Keywords: HPV; cutaneous; retinoids; viral; warts.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

REFERENCES

    1. Sterling JC, Gibbs S, Haque Hussain SS, et al. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696-712.
    1. Bruggink SC, Eekhof JA, Egberts PF, et al. Natural course of cutaneous warts among primary schoolchildren: a prospective cohort study. Ann Fam Med. 2013;11(5):437-441.
    1. Leman JA, Benton EC. Verrucas: guidelines for management. Am J Clin Dermatol. 2000;1(3):143-149.
    1. Dall'oglio F, D'Amico V, Nasca MR, et al. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13(2):73-96.
    1. Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006;4(4):273-293.